Recombinant Human CDKN2A

category

Proteins and Peptides

origin

Human

host

E.Coli

immunogen target

1-156

host

E.Coli

form

Lyophilized from a 0.2um filtered solution in PBS with 5% trehalose, pH7.4

tested applications

Western Blot，ELISA

size 1

50μg

size 2

200μg

size 3

1mg

observerd MW

17.1 kDa

expression

Recombinant

purity

Greater than 95% by SDS-PAGE gel analyses

purification

His tag

buffer

Reconstitute with Sterile distilled water

storage

-20°C for 12 months as lyophilized;2-8°C for 1 month under sterile conditions after reconstitution

or code

CDKN2A

availability

3-4 weeks

alias

Alternative reading frame, ARF, CDK4 inhibitor p16 INK4, CDK4I, CDKN2, cell cycle negative regulator beta, CMM2, cyclin dependent kinase 4 inhibitor A, cyclin dependent kinase inhibitor 2A, cyclin dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLM, MTS 1, MTS1, multiple tumor suppressor 1, P14, P14ARF, P16, P16 INK4A, P16INK4, P16INK4A, P19, P19ARF, TP16

uniprot id

note

This product is for research use only.